Limited flow reserve in non-obstructed bypass grafts supplying infarcted myocardium: implications for cardiovascular

Christian Spies1, Oliver K Mohrs, James R Madison

  • 1Rush University Medical Center Section of Cardiology 1653 West Congress Parkway Chicago, IL 60612 USA. christian_spies@rush.edu

Insights

Flow reserve is reduced in bypass grafts supplying infarcted heart muscle compared to healthy tissue. Cardiovascular magnetic resonance assessment requires myocardial viability testing for accurate bypass evaluation.

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging

Background:

  • Non-obstructed bypass grafts are crucial for myocardial perfusion.
  • Assessing bypass graft function is essential for patient outcomes.
  • Myocardial viability influences bypass graft performance.

Purpose of the Study:

  • To evaluate flow reserve in non-obstructed bypass grafts supplying infarcted versus noninfarcted myocardium.
  • To determine the impact of myocardial infarction on bypass graft flow reserve.
  • To highlight the importance of myocardial viability assessment in bypass evaluation.

Main Methods:

  • Phase-contrast flow measurements were used to assess bypass grafts.
  • Late enhancement cardiovascular magnetic resonance (CMR) was employed for myocardial viability assessment.
  • Flow reserve was calculated and compared between groups.

Main Results:

  • Flow reserve was significantly higher in bypasses supplying normal myocardium (2.9) versus infarcted myocardium (1.5) (p<.0001).
  • Bypass grafts supplying infarcted myocardium were more likely to have reduced flow reserve (< or =2, 84% vs 18%, p = .0003).
  • Reduced flow reserve in grafts supplying infarcted myocardium persisted after adjusting for co-variables.

Conclusions:

  • Non-stenosed bypass grafts supplying infarcted myocardium exhibit reduced flow reserve.
  • Altered myocardial microcirculation likely contributes to decreased flow reserve in infarcted areas.
  • Cardiovascular magnetic resonance bypass assessment necessitates integrating myocardial viability testing.